|
Monday, February 28 — 8:00 AM — CC 103 A/B
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section B - Hematopathology
Chaired by: Kyle Bradley and Ahmet Dogan
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
"In Situ" Mantle Cell Lymphoma (MCL), an Incidental Finding with an Indolent Clinical Course.
(1228)
A Carvajal, L Sua, N Silva, S Pittaluga, C Royo, RL Sargent, F Climent, SA Jacobs, J Delabie, K Naresh, A Bagg, NL Harris, SH Swerdlow, ES Jaffe, E Campo - Hospital Clinic, Barcelona, Spain; MD Anderson Cancer Ctr, Houston, TX; University of Pittsburgh, PA; Oslo University Hospital, Norway; Hammersmith Hospital, London, United Kingdom; Hospital of the University of Pennsylvania, Philadelphia; Massachusetts General Hospital, Boston; National Cancer Institute, Bethesda, MD
|  Add |
| 8:15 |
The Proportion of Tumor Cells Expressing SOX11 Is Associated with Progression Free Survival in Mantle Cell Lymphoma.
(1223)
L Brandi, G Shaw, K Grindle, S Seo, B Kahl, C Leith, K Young, D Yang - University of Wisconsin, Madison; Marshfield Clinic
| Add |
| 8:30 |
SOX11 Expression in B-Cell Lymphoma and Identification of the First Putative Cases of Cyclin D1-Negative Blastoid Mantle Cell Lymphoma.
(1410)
W Zeng, K Fu, MS Lim, N Kumar, S Ondrejka, E Hsi - Cleveland Clinic; University of Nebraska Medical Center, Nebraska; University of Michigan, Ann Arbor
| Add |
| 8:45 |
Stapled BIM BH3 Helix Restores Apoptosis in BIM-Null Mantle Cell Lymphoma.
(1295)
SG Katz, JL LaBelle, M Godes, JK Fisher, GH Bird, LD Walensky - Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute and Children's Hospital Boston, Harvard Medical School, Boston, MA
| Add |
| 9:00 |
Overexpression of Lymphoid Enhancer Binding Factor 1 (LEF-1) Is Highly Associated with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in Small B-Cell Lymphomas.
(1376)
B Tandon, J Gao, L Peterson, Y-H Chen - Northwestern University Feinberg School of Medicine, Chicago, IL
| Add |
| 9:15 |
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Transformation to Histiocytic/Dendritic Cell Sarcoma: Alterations of 17p as a Potential Risk Factor.
(1363)
H Shao, L Xi, M Raffeld, AL Feldman, RP Ketterling, R Knudson, J Rodriguez-Canales, J Hanson, S Pittaluga, ES Jaffe - Center for Cancer Research, National Cancer Institute, Bethesda, MD; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Mayo Clinic, Rochester, MN
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
microRNA Profiling of Follicular Lymphoma and Tumor Infiltrating T-Cells.
(1391)
W Wang, R Plyler, JE Janik, ES Jaffe, KR Calvo - NIH Clinical Center, Bethesda, MD; National Cancer Institute, Besthesda, MD
| Add |
| 11:15 |
EZH2 Codon 641 Mutations Are Common in BCL2-Rearranged B Cell Lymphomas.
(1355)
RJH Ryan, M Nitta, D Borger, AJ Iafrate, L Zukerberg, A Sohani, L Le - Mass General Hospital, Boston
| Add |
| 11:30 |
Promoter and Exon 1 Hypermethylation of the Tumor Suppressor Gene PRDM 1/Blimp-1 Indicates Its Pathogenetic Role in EBV(+) Burkitt Lymphoma.
(1402)
J Yan, T Zhang, CE Bacchi, EM Queiroga, G Gualco, K Nie, Y Liu, S Barouk, A Orazi, DM Knowles, W Tam - Weill Cornell Medical College, New York, NY; Consultoria em Patologia, Botucatu, SP, Brazil
| Add |
| 11:45 |
Gene Expression Profiling by a Quantitative Nuclease Protection Assay (qNPA) but Not Immunohistochemical Algorithms Predicts Clinical Outcome in Diffuse Large B-Cell Lymphoma.
(1253)
A Dogan, N Ozsan, M Mai, JA Vrana, MJ Maurer, TM Habermann, BL Caron, JR Cerhan, RF McClure - Mayo Clinic, Rochester, MN
| Add |
|
|
